Similar articles

• How do Orthopaedic Devices Change After Their Initial FDA Premarket Approval?

  Samuel AM, Rathi VK, Grauer JN, Ross JS. Samuel AM, et al. Clin Orthop Relat Res. 2016 Apr;474(4):1053-68. doi: 10.1007/s11999-015-4634-x. Epub 2015 Nov 19. Clin Orthop Relat Res. 2016. PMID: 26584802 Free PMC article.
• Strengths and weaknesses of FDA-approved/cleared diagnostic devices for the molecular detection of respiratory pathogens.

  Ginocchio CC. Ginocchio CC. Clin Infect Dis. 2011 May;52 Suppl 4(Suppl 4):S312-25. doi: 10.1093/cid/cir046. Clin Infect Dis. 2011. PMID: 21460290 Free PMC article.
• Analysis of FDA-Approved Orthopaedic Devices and Their Recalls.

  Day CS, Park DJ, Rozenshteyn FS, Owusu-Sarpong N, Gonzalez A. Day CS, et al. J Bone Joint Surg Am. 2016 Mar 16;98(6):517-24. doi: 10.2106/JBJS.15.00286. J Bone Joint Surg Am. 2016. PMID: 26984921 Review.
• Postmarketing Safety-Related Modifications of Drugs Approved by the US Food and Drug Administration Between 1999 and 2014 Without Randomized Controlled Trials.

  Shepshelovich D, Tibau A, Goldvaser H, Ocana A, Seruga B, Amir E. Shepshelovich D, et al. Mayo Clin Proc. 2019 Jan;94(1):74-83. doi: 10.1016/j.mayocp.2018.07.027. Mayo Clin Proc. 2019. PMID: 30611457
• New Drugs Approved in 2019.

  Ebied AM, Patel KH, Cooper-DeHoff RM. Ebied AM, et al. Am J Med. 2020 Jun;133(6):675-678. doi: 10.1016/j.amjmed.2020.01.030. Epub 2020 Mar 5. Am J Med. 2020. PMID: 32145207 Review.